Jasmine Lowdon spent years feeling miserable during the summer months because of her condition - despite having 'tried ...

Antihistamines for allergic rhinitis have experienced major commercial ... Additionally, the incorrect use of the intranasal delivery device led to adverse events, such as nose bleeds, when ...

Objective: Corticosteroids are effective in controlling the inflammatory component of allergic rhinitis; however, evidence for the clinical efficacy of systemic corticosteroids in this disease is ...

(HKEX: 02162)�("Keymed" or the "Company") today announced that the prestigious medical journal Nature Medicine has published the results from the Phase III trial of its independently developed�IL-4Ra ...

Market OverviewThe global Allergic Rhinitis Drugs Market is valued at USD 1.90 Billion in 2024 and is projected to reach a value of USD 2.868 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of ...

Seasonal allergies, particularly hay fever, are worsening due to longer pollen seasons. Early medication and immunotherapy ...

Allergy seasons are expected to get longer and grow more intense as climate change progresses, researchers say. Total pollen emissions are projected to increase as much as 40% by the end of the ...

The prospective, interventional, randomized, double-blind, placebo-controlled, monocentric clinical trial was conducted with 40 people with acute allergic rhinitis. The study results found a daily ...

New research shows how climate change is making allergy seasons worse—and how meat production plays a hidden role in fueling ...

Keymed Biosciences Inc. (HKEX: 02162) ("Keymed" or the "Company") today announced that the prestigious medical journal Nature Medicine has published ...